Providing IPS-based Platforms for Pharma & Research Institutions

Our future is bright! StemoniX is recognized for demonstrating "significant potential, creativity and a promising future" winning the 2017 Minnesota Tekne Award! Read More

No Records

Structure Leads to Improved Cell-Based Assay Outcomes

StemoniX provides products and services for drug discovery and development. We structure human iPSC-derived cells into physiologically relevant microtissues with accelerated cell maturity that mimic the native organ tissue. Predictive, accurate, and consistent, our in vitro human cell-based products enable scientists to quickly and economically conduct research with improved outcomes in a simplified workflow.

Products and Services

microBrain® 3D Assay Ready

Human, iPSC-derived cortical spheroids pre-plated for high throughput screening and drug discovery
Read more

microBrain® Assay Ready

Mature, balanced culture of human iPSC-derived cortical neurons and astrocytes pre-plated in high density screening plates
Read more

Neural Progenitor Cells

Multipotent human iPSC-derived NPCs in a cryopreserved format that can consistently generate high yields of functional cortical neurons and astrocytes
Read more

microHeart® Assay Ready

Structured human cardiomyocytes pre-plated in high density screening plates to match native human heart tissue
Read more  

microHeart® Cell Ready

Novel high density screening plates that align plated cardiomyocytes into physiologically relevant structures for drug discovery and development
Read more  

Discovery as a Service

StemoniX offers drug discovery and development capabilities for in vitro disease modeling, assay development, functional and phenotypic high throughput compound screening, and custom iPS cell manufacturing
Read more

Why StemoniX?

We grow, differentiate, and print organ cells from skin cells, in a way that makes them biologically accurate, to better predict their toxicity and improve efficacy.

infoicon

Blue: DNA staining of fibroblasts highlighting their nuclei

Red: Phalloidin staining of Actin Cytoskeleton

Our technology includes the ability to create a variety of organ cells that can mimic diseases to help accelerate the discovery of new cures in the areas of heart disease, dementia and neuromuscular diseases.

Why StemoniX?

About Us

Our team and scientific board have vetted StemoniX IP with over $200M and a track record of success

30+
Patents
30+
Patents
Pending
Co-founded
9
successful
companies
Authored
7
books

Meet the StemoniX Team

MS, MBA, PMP, PgMP, Ping has formed and led teams to producing world-changing devices. His expertise focuses on merging core intellectual property from startups to F100 corporations.
Ping Yeh | Founder & CEO
Dr. Bob Petcavich, Cofounder & Chief Science Advisor of StemoniX, is a successful serial inventor and entrepreneur, holding nearly 60 patents.
Robert Petcavich | Co-founder
PhD in cell-based assays for high throughput cancer drug discovery. A leader at the Dept. of Medicine & Division of Cardiology at University of California, San Diego.
Fabian Zanella | Head of Cell Biology
MD MBA FACEP, Dr. Khaleghi has led the personalized medicine process for WellnessFX as their medical director. He has also served as CMIO of the Noble Health System, and published 6 health books.
Murdoc Khaleghi | Chief Medical Officer

StemoniX Connections:

What are you interested in?   

Please leave this field empty.